Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.09%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
6.54 Down 0.05(0.76%) Dec 9, 4:00PM EST
Prev Close:6.59
Open:6.61
Bid:6.36 x 700
Ask:6.66 x 2500
1y Target Est:21.00
Beta:1.96609
Earnings Date:Feb 22 - Feb 27 (Est.)
Day's Range:6.36 - 6.81
52wk Range:4.45 - 9.74
Volume:2,572,553
Avg Vol (3m):1,966,420
Market Cap:853.23M
P/E (ttm):N/A
EPS (ttm):-1.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 0.76%853.23M
IMGNDown 2.65%160.63M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):119.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.33
Quarterly EPS Est (Dec-16) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback